Clofazimine for the treatment of multidrug-resistant tuberculosis

Lange Christoph G.; Chesov Dumitru; Heyckendorf Jan

Conţinutul numărului revistei

Articolul precedent

Articolul urmator

329

SM ISO690:2012

LANGE, Christoph G., CHESOV, Dumitru, HEYCKENDORF, Jan. Clofazimine for the treatment of multidrug-resistant tuberculosis. In: Clinical Microbiology and Infection, 2019, nr. 2(25), pp. 128-130. ISSN 1198-743X. DOI: https://doi.org/10.1016/j.cmi.2018.11.010

EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core

Clinical Microbiology and Infection

Numărul 2(25) / 2019 / ISSN 1198-743X /ISSNe 1469-0691

Clofazimine for the treatment of multidrug-resistant tuberculosis

DOI:https://doi.org/10.1016/j.cmi.2018.11.010

Pag. 128-130

Lange Christoph G.¹²³, Chesov Dumitru¹⁴, Heyckendorf Jan¹

¹ Research Center Borstel,
² University of Lübeck,
³ Karolinska Institutet, Stockholm,
⁴ ”Nicolae Testemițanu” State University of Medicine and Pharmacy

Disponibil în IBN: 4 mai 2021

Cuvinte-cheie
Antitubercular Agents, Clofazimine, Humans, tuberculosis, Multidrug-Resistant

Crossref XML Export

<?xml version='1.0' encoding='utf-8'?>
<doi_batch version='4.3.7' xmlns='http://www.crossref.org/schema/4.3.7' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xsi:schemaLocation='http://www.crossref.org/schema/4.3.7 http://www.crossref.org/schema/deposit/crossref4.3.7.xsd'>
<head>
<doi_batch_id>ibn-128805</doi_batch_id>
<timestamp>1714198074</timestamp>
<depositor>
<depositor_name>Information Society Development Instiute, Republic of Moldova</depositor_name>
<email_address>idsi@asm.md</email_address>
</depositor>
</head>
<body>
<journal>
<journal_metadata>
<full_title>Clinical Microbiology and Infection</full_title>
<issn media_type='print'>1198743X</issn>
</journal_metadata>
<journal_issue>
<publication_date media_type='print'>
<year>2019</year>
</publication_date>
<issue>2(25)</issue>
</journal_issue>
<journal_article publication_type='full_text'><titles>
<title>Clofazimine for the treatment of multidrug-resistant tuberculosis</title>
</titles>
<contributors>
<person_name sequence='first' contributor_role='author'>
<given_name>Christoph G.</given_name>
<surname>Lange</surname>
</person_name>
<person_name sequence='additional' contributor_role='author'>
<given_name>Dumitru</given_name>
<surname>Chesov</surname>
</person_name>
<person_name sequence='additional' contributor_role='author'>
<given_name>Jan</given_name>
<surname>Heyckendorf</surname>
</person_name>
</contributors>
<publication_date media_type='print'>
<year>2019</year>
</publication_date>
<pages>
<first_page>128</first_page>
<last_page>130</last_page>
</pages>
<doi_data>
<doi>10.1016/j.cmi.2018.11.010</doi>
<resource>http://www.crossref.org/</resource>
</doi_data>
</journal_article>
</journal>
</body>
</doi_batch>